Sovipostobart is an immunoglobulin G1-kappa, anti-CTLA-4 human monoclonal antibody with cleavable prodomain. Sovipostobart is an immunostimulant and antineoplastic[1].
Molecular Weight:
(153.531 kDa)
Purity:
96.528
CAS Number:
[2649371-19-5]
Target:
CTLA-4
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted